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INVITED COMMENTARY
Thomas W. Wakefield, MD, Ann Arbor, Mich
This interesting study by Dr Pavcnik and his group expands
and extends their previous work on the development of an
artificial venous valve. Despite initial promising results, their
most recent data suggest that a different approach may be
needed than a totally artificial venous valve. Building upon
pioneering work by a number of authors, they present an
elegant study in an ovine animal model in which they demon-
strate the feasibility of transplanting a valve from one jugular
vein to another jugular vein percutaneously. This is performed by
attaching the intact vein with its competent valve inside a stent.
They demonstrate at 3months intact, flexible, non-thickened valve
leaflets that were competent by phlebography and angioscopy,
with excellent microscopic analysis. They appropriately point out
the short follow-up of their study and the need for further long-
term data.
This approach, utilizing an autologous vein, is subject to the
same limitation as current valve transplantation procedures, that
being the need to find a competent valve to transplant. However,
potential advantages include the percutaneous delivery which will
avoid an often difficult recipient vein dissection, especially in the
postthrombotic vein, and the associated risk of perioperative
bleeding in the surgical field with the use of anticoagulation.
Additionally, it has been suggested that transplanted venous valves
may become incompetent as the vein segment dilates, leading
some to wrap their transplanted vein valves with material such as
expanded polytetrafluroethylene, to prevent dilatation. Unfortu-
nately, this may lead to significant perivenous inflammation and
scarring. The stent should act as a barrier to vein dilation and
subsequent valve incompetence.
With the large number of patients affected by chronic venous
insufficiency worldwide, the potential for a solution to the valve
incompetence problem has great clinical potential to supplement
and supplant our current treatment. Although the approach pre-
sented here will require more experimentation and longer follow-
up, the results of the current study provide considerable excite-
ment for this unqiue and timely approach.
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